People with severe mental illness (SMI) may be at increased risk for several adverse health conditions, including HIV/AIDS. This disproportionate disease burden has been studied primarily at the individual rather than community level, in part due to the rarity of data sources linking individual information on medical and mental health characteristics with community-level data. We demonstrated the potential of Medicaid data to address this gap.
Methods.
We analyzed data on Medicaid beneficiaries with schizophrenia from eight states that account for 66% of cumulative AIDS cases nationally.
Results.
Across 44 metropolitan statistical areas (MSAs), the treated prevalence of HIV among adult Medicaid beneficiaries diagnosed with schizophrenia was 1.56% (standard deviation = 1.31%). To explore possible causes of variation, we linked claims files with a range of MSA social and contextual variables including local AIDS prevalence rates, area-based economic measures, crime rates, substance abuse treatment resources, and estimates of injection drug users (IDUs) and HIV infection among IDUs, which strongly predicted community infection rates among people with schizophrenia.
Conclusions.
Effective strategies for HIV prevention among people with SMI may include targeting prevention efforts to areas where risk is greatest; examining social network links between IDU and SMI groups; and implementing harm reduction, drug treatment, and other interventions to reduce HIV spread among IDUs. Our findings also suggest the need for research on HIV among people with SMI that examines geographical variation and demonstrates the potential use of health-care claims data to provide epidemiologic insights into small-area variations and trends in physical health among those with SMI.
References
1.
ParksJSvendsenDSingerPFotiME, Morbidity and mortality in people with serious mental illness. Thirteenth in a series of technical reports. Alexandria (VA): National Association of State Mental Health Program Directors; 2006.
2.
ColtonCWManderscheidRW, Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis2006;3:A42.
3.
SahaSChantDMcGrathJ.A systematic review of mortality in schizophrenia: Is the differential mortality gap worsening over time?Arch Gen Psychiatry2007;64:1123–31.
4.
WeberNSCowanDNMillikanAMNiebuhrDW, Psychiatric and general medical conditions comorbid with schizophrenia in the National Hospital Discharge Survey. Psychiatr Serv2009;60:1059–67.
5.
von Hausswolff-JuhlinYBjartveitMLindstromEJonesP.Schizophrenia and physical health problems. Acta Psychiatr Scand Suppl2009;(438):15–21.
6.
BravemanP.Health disparities and health equity: Concepts and measurement. Annu Rev Public Health2006;27:167–94.
7.
AdlerNERehkopfDH, U.S. disparities in health: Descriptions, causes, and mechanisms. Annu Rev Public Health2008;29:235–52.
8.
BlankMBMandellDSAikenLHadleyTR, Co-occurrence of HIV and serious mental illness among Medicaid recipients. Psychiatr Serv2002;53:868–73.
9.
CrystalSAkincigilABilderSWalkupJT, Studying prescription drug use and outcomes with Medicaid claims data: Strengths, limitations, and strategies. Med Care2007;45(10 Suppl 2):S58–65.
10.
HooverDRSambamoorthiUWalkupJTCrystalS.Mental illness and length of inpatient stay for Medicaid recipients with AIDS. Health Serv Res2004;39:1319–39.
11.
WalkupJWeiWSambamoorthiUCrystalS.Antidepressant treatment and adherence to combination antiretroviral therapy among patients with AIDS and diagnosed depression. Psychiatr Q2008;79:43–53.
12.
WalkupJCrystalSSambamoorthiU.Schizophrenia and major affective disorder among Medicaid recipients with HIV/AIDS in New Jersey. Am J Public Health1999;89:1101–3.
13.
NakashimaAKFlemingPL, HIV/AIDS surveillance in the United States, 1981–2001. J Acquir Immune Defic Syndr2003;32Suppl 1:S68–85.
14.
SullivanPSMcKennaMTJanssenRS, Progress toward implementation of integrated systems for surveillance of HIV infection and morbidity in the United States. Public Health Rep2007;122Suppl 1:1–3.
15.
McNaghtenADWolfeMIOnoratoINakashimaAKValdiserriROMokotoffE, Improving the representativeness of behavioral and clinical surveillance for persons with HIV in the United States: The rationale for developing a population-based approach. PLoS One2007;2:e550.
16.
HolmesWCBixBMeritzMTurnerJHutelmyerC.Human immunodeficiency virus (HIV) infection and quality of life: The potential impact of Axis I psychiatric disorders in a sample of 95 HIV seropositive men. Psychosom Med1997;59:187–92.
17.
WilliamsJBRabkinJGRemienRHGormanJMEhrhardtAA, Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection: II. Standardized clinical assessment of current and lifetime psychopathology. Arch Gen Psychiatry1991;48:124–30.
18.
CournosFMcKinnonK.HIV seroprevalence among people with severe mental illness in the United States: A critical review. Clin Psychol Rev1997;17:259–69.
19.
CareyMPCournosF.HIV and AIDS among the severely mentally ill: Introduction to the special series. Clin Psychol Rev1997;17:241–5.
20.
McKinnonKCareyMPCournosF.Research on HIV, AIDS, and severe mental illness: Recommendations from the NIMH National Conference. Clin Psychol Rev1997;17:327–31.
21.
BeyerJLTaylorLGersingKRKrishnanKR, Prevalence of HIV infection in a general psychiatric outpatient population. Psychosomatics2007;48:31–7.
22.
RosenbergSDGoodmanLAOsherFCSwartzMSEssockSMButterfieldMI, Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. Am J Public Health2001;91:31–7.
23.
HimelhochSMcCarthyJFGanoczyDMedoffDDixonLBBlowFC, Understanding associations between serious mental illness and HIV among patients in the VA Health System. Psychiatr Serv2007;58:1165–72.
24.
BlankMBMandellDSAikenLHadleyTR, Co-occurrence of HIV and serious mental illness among Medicaid recipients. Psychiatr Serv2002;53:868–73.
25.
StoskopfCHKimYKGloverSH, Dual diagnosis: HIV and mental illness, a population-based study. Community Ment Health J2001;37:469–79.
26.
CareyMPCareyKBKalichmanSC, Risk for human immunodeficiency virus (HIV) infection among persons with severe mental illnesses. Clin Psychol Rev1997;17:271–91.
27.
CareyMPCareyKBMaistoSAGleasonJRGordonCMBrewerKK, HIV risk behavior among outpatients at a state psychiatric hospital: Prevalence and risk modeling. Behavior Ther1999;30:389–406.
28.
McKinnonKCournosFHermanR.A lifetime alcohol or other drug use disorder and specific psychiatric symptoms predict sexual risk for HIV infection among people with severe mental illness. AIDS Behav2001;5:233–40.
29.
MeadeCSSikkemaKJ, Psychiatric and psychosocial correlates of sexual risk behavior among adults with severe mental illness. Community Ment Health J2007;43:153–69.
30.
GottesmanIIGroomeCS, HIV/AIDS risks as a consequence of schizophrenia. Schizophr Bull1997;23:675–84.
31.
MeadeCSWeissRD, Substance abuse as a risk factor for HIV sexual risk behavior among persons with severe mental illness: Review of evidence and exploration of mechanisms. Clin Psychol2007;14:23–33.
32.
MeadeCSSikkemaKJ, HIV risk behavior among adults with severe mental illness: A systematic review. Clin Psychol Rev2005;25:433–57.
33.
TuckerJSKanouseDEMiuAKoegelPSullivanG.HIV risk behaviors and their correlates among HIV-positive adults with serious mental illness. AIDS Behav2003;7:29–40.
34.
KellyJA, HIV risk reduction interventions for persons with severe mental illness. Clin Psychol Rev1997;17:293–309.
35.
BerkmanAPilowskyDJZybertPAHermanDBConoverSLemelleS, HIV prevention with severely mentally ill men: A randomised controlled trial. AIDS Care2007;19:579–88.
36.
CastorDPilowskyDJHaddenBFullerCOmpadDCde LeonCL, Sexual risk reduction among non-injection drug users: Report of a randomized controlled trial. AIDS Care2010;22:62–70.
37.
BerkmanAPilowskyDJZybertPALeuCSSohlerNSusserE.The impact of substance dependence on HIV sexual risk-reduction among men with severe mental illness. AIDS Care2005;17:635–9.
38.
CareyMPCareyKBMaistoSASchroderKEVanablePAGordonCM, HIV risk behavior among psychiatric outpatients: Association with psychiatric disorder, substance use disorder, and gender. J Nerv Ment Dis2004;192:289–96.
39.
CareyMPCareyKBKalichmanSC, Risk for human immunodeficiency virus (HIV) infection among persons with severe mental illnesses. Clin Psychol Rev1997;17:271–91.
40.
RosenbergSDTrumbettaSLMueserKTGoodmanLAOsherFCVidaverRM, Determinants of risk behavior for human immunodeficiency virus/acquired immunodeficiency syndrome in people with severe mental illness. Compr Psychiatry2001;42:263–71.
41.
KrakowDSGalanterMDermatisHWestreichLM, HIV risk factors in dually diagnosed patients. Am J Addict1998;7:74–80.
42.
SilbersteinCGalanterMMarmorMLifshutzHKrasinskiKFrancoH.HIV-1 among inner city dually diagnosed inpatients. Am J Drug Alcohol Abuse1994;20:101–13.
43.
FrankRGMcGuireTGRegierDAManderscheidRWoodwardA.Paying for mental health and substance abuse care. Health Aff (Millwood)1994;13:337–42.
44.
MarkTLCoffeyRMVandivort-WarrenRHarwoodHJKingEC; MHSA Spending Estimates Team. U.S. spending for mental health and substance abuse treatment, 1991–2001. Health Aff (Millwood)2005;Suppl Web Exclusives: W5–133-W5–142.
45.
RhodesTSingerMBourgoisPFriedmanSRStrathdeeSA, The social structural production of HIV risk among injecting drug users. Soc Sci Med2005;61:1026–44.
46.
Centers for Disease Control and Prevention (US). HIV/AIDS surveillance report, 2001 (Vol. 13). Atlanta: CDC; 2001.
47.
SusserEMillerMValenciaEColsonPRocheBConoverS.Injection drug use and risk of HIV transmission among homeless men with mental illness. Am J Psychiatry1996;153:794–8.
48.
RobertsETFriedmanSRBradyJEPougetERTempalskiBGaleaS.Environmental conditions, political economy, and rates of injection drug use in large US metropolitan areas 1992–2002. Drug Alcohol Depend2010;106:142–53.
49.
TempalskiBMcQuieH.Drugscapes and the role of place and space in injection drug use-related HIV risk environments. Int J Drug Policy2009;20:4–13.
50.
Department of Health and Human Services (US), Centers for Medicare and Medicaid Services. Medicaid Analytic eXtract (MAX) general information [cited 2008 Jan 10]. Available from: URL: http://www.resdac.org/Medicaid/data_available.asp.
51.
LurieNPopkinMDyskenMMoscoviceIFinchM.Accuracy of diagnoses of schizophrenia in Medicaid claims. Hosp Community Psychiatry1992;43:69–71.
52.
WalkupJTBoyerCAKellermannSL, Reliability of Medicaid claims files for use in psychiatric diagnoses and service delivery. Adm Policy Ment Health2000;27:129–39.
53.
BagchiASambamoorthiUMcSpirittEYanosPWalkupJCrystalS.Use of antipsychotic medications among HIV-infected individuals with schizophrenia. Schizophr Res2004;71:435–44.
54.
SambamoorthiUWalkupJMcSpirittEWarnerLCastleNCrystalS.Racial differences in end-of-life care for patients with AIDS. AIDS Public Policy J2000;15:136–48.
55.
WalkupJAkincigilABilderSRosatoNSCrystalS.Psychiatric diagnosis and antiretroviral adherence among adolescent Medicaid beneficiaries diagnosed with human immunodeficiency virus/acquired immunodeficiency syndrome. J Nerv Ment Dis2009;197:354–61.
56.
WalkupJSambamoorthiUCrystalS.Incidence and consistency of antiretroviral use among HIV-infected Medicaid beneficiaries with schizophrenia. J Clin Psychiatry2001;62:174–8.
57.
WalkupJTWeiWSambamoorthiUCrystalS.Sensitivity of an AIDS case-finding algorithm: Who are we missing?Med Care2004;42:756–63.
Centers for Disease Control and Prevention (US). HIV/AIDS surveillance report, 2003 (Vol. 15) [cited 2009 Dec 18]. Available from: URL: http://www.cdc.gov/hiv/stats/hasrlink.htm.
TempalskiBLiebSClelandCMCooperHBradyJEFriedmanSR, HIV prevalence rates among injection drug users in 96 large US metropolitan areas, 1992–2002. J Urban Health2009;86:132–54.
62.
Department of Housing and Urban Development (US). State of the cities data systems (SOCDS) [cited 2009 Aug 27]. Available from: URL: http://socds.huduser.org/SOCDS_Home.htm.
63.
Department of Justice (US), Federal Bureau of Investigation. Uniform Crime Reporting program data [United States]: County-level detailed arrest and offense data. Washington: Department of Justice, FBI; 2009.
64.
Department of Health and Human Services (US), Substance Abuse and Mental Health Services Administration. DASIS [Drug & Alcohol Services Information System]. National Survey of Substance Abuse Treatment Services (N-SSATS) [cited 2008 Feb 1]. Available from: URL: http://wwwdasis.samhsa.gov/dasis2/nssats.htm.
65.
BradyJEFriedmanSRCooperHLFlomPLTempalskiBGostnellK.Estimating the prevalence of injection drug users in the U.S. and in large U.S. metropolitan areas from 1992 to 2002. J Urban Health2008;85:323–51.
66.
KriegerNChenJTWatermanPDRehkopfDHSubramanianSV, Painting a truer picture of US socioeconomic and racial/ethnic health inequalities: The Public Health Disparities Geocoding Project. Am J Public Health2005;95:312–23.
67.
KriegerNWatermanPDChenJTSoobaderMJSubramanianSV, Monitoring socioeconomic inequalities in sexually transmitted infections, tuberculosis, and violence: Geocoding and choice of area-based socioeconomic measures—the Public Health Disparities Geocoding Project (US). Public Health Rep2003;118:240–60.
68.
KriegerNWilliamsDRMossNE, Measuring social class in US public health research: Concepts, methodologies, and guidelines. Annu Rev Public Health1997;18:341–78.
69.
SAS Institute, Inc.SAS®: Version 9.2. Cary (NC): SAS Institute, Inc.; 2008.
70.
StataCorpLP, Stata®: Version 9.2. College Station (TX): StataCorp LP; 2006.
71.
GarfeinRSMonterrosoERTongTCVlahovDDes JarlaisDCSelwynP, Comparison of HIV infection risk behaviors among injection drug users from East and West Coast US cities. J Urban Health2004;81:260–7.
72.
HolmbergSD, The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am J Public Health1996;86:642–54.
73.
FriedmanSRLiebSTempalskiBCooperHKeemMFriedmanR, HIV among injection drug users in large US metropolitan areas, 1998. J Urban Health2005;82:434–45.
74.
FriedmanSRTempalskiBCooperHPerlisTKeemMFriedmanR, Estimating numbers of injecting drug users in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for injecting drug users. J Urban Health2004;81:377–400.
75.
PerryBLWrightER, The sexual partnerships of people with serious mental illness. J Sex Res2006;43:174–81.
76.
WrightERWrightDEPerryBLFoote-ArdahCE, Stigma and the sexual isolation of people with serious mental illness. Soc Problems2007;54:78–98.
77.
DinwiddieSHCottlerLComptonWAbdallahAB, Psychopathology and HIV risk behaviors among injection drug users in and out of treatment. Drug Alcohol Depend1996;43:1–11.
78.
LipsitzJDWilliamsJBRabkinJGRemienRHBradburyMel SadrW, Psychopathology in male and female intravenous drug users with and without HIV infection. Am J Psychiatry1994;151:1662–8.
79.
RabkinJGJohnsonJLinSHLipsitzJDRemienRHWilliamsJB, Psychopathology in male and female HIV-positive and negative injecting drug users: Longitudinal course over three years. AIDS1997;11:507–15.
80.
KidorfMDisneyERKingVLNeufeldKBeilensonPLBroonerRK, Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program. Drug Alcohol Depend2004;74:115–22.
81.
Ryan White Comprehensive AIDS Resources Emergency (CARE) Act. Pub. L. No. 101–381, 104 Stat. 576 (1990).
82.
The Henry J. Kaiser Family Foundation. HIV/AIDS policy fact sheet: AIDS Drug Assistance Programs (ADAPs), April2008 [cited 2010 Jun 1]. Available from: URL: http://www.kff.org/hivaids/upload/1584_09.pdf.
83.
WalkupJTCrystalS.Mental health and the changing contexts of HIV. In: ScheidTLBrownTN, editors. A handbook for the study of mental health: Social contexts, theories, and systems. 2nd ed. New York: Cambridge University Press; 2009. p. 548–70.
84.
WagnerGJKanouseDEKoegelPSullivanG.Adherence to HIV antiretrovirals among persons with serious mental illness. AIDS Patient Care STDS2003;17:179–86.
85.
WagnerGJKanouseDEKoegelPSullivanG.Correlates of HIV antiretroviral adherence in persons with serious mental illness. AIDS Care2004;16:501–6.
86.
Des JarlaisDCArastehKPerlisTHaganHAbdul-QuaderAHeckathornDD, Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. AIDS2007;21:231–5.
87.
Des JarlaisDCPerlisTArastehKHaganHMillikenJBraineN, “Informed altruism” and “partner restriction” in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990–2001. J Acquir Immune Defic Syndr2004;35:158–66.
